Hu Fen, Pan Leiting, Zhang Kai, Xing Fulin, Wang Xinyu, Lee Imshik, Zhang Xinzheng, Xu Jingjun
The Key Laboratory of Weak-Light Nonlinear Photonics, Ministry of Education, TEDA Applied Physics Institute and School of Physics, Nankai University, Tianjin, China.
PLoS One. 2014 Sep 25;9(9):e107217. doi: 10.1371/journal.pone.0107217. eCollection 2014.
The local concentration of extracellular Ca(2+) ([Ca(2+)]o) in bone microenvironment is accumulated during bone remodeling. In the present study we investigated whether elevating [Ca(2+)]o induced store-operated calcium entry (SOCE) in primary rat calvarial osteoblasts and further examined the contribution of elevating [Ca(2+)]o to osteoblastic proliferation.
Cytosolic Ca(2+) concentration ([Ca(2+)]c) of primary cultured rat osteoblasts was detected by fluorescence imaging using calcium-sensitive probe fura-2/AM. Osteoblastic proliferation was estimated by cell counting, MTS assay and ATP assay. Agonists and antagonists of calcium-sensing receptors (CaSR) as well as inhibitors of phospholipase C (PLC), SOCE and voltage-gated calcium (Cav) channels were applied to study the mechanism in detail.
Our data showed that elevating [Ca(2+)]o evoked a sustained increase of [Ca(2+)]c in a dose-dependent manner. This [Ca(2+)]c increase was blocked by TMB-8 (Ca(2+) release inhibitor), 2-APB and BTP-2 (both SOCE blockers), respectively, whereas not affected by Cav channels blockers nifedipine and verapamil. Furthermore, NPS2143 (a CaSR antagonist) or U73122 (a PLC inhibitor) strongly reduced the [Ca(2+)]o-induced [Ca(2+)]c increase. The similar responses were observed when cells were stimulated with CaSR agonist spermine. These data indicated that elevating [Ca(2+)]o resulted in SOCE depending on the activation of CaSR and PLC in osteoblasts. In addition, high [Ca(2+)]o significantly promoted osteoblastic proliferation, which was notably reversed by BAPTA-AM (an intracellular calcium chelator), 2-APB, BTP-2, TMB-8, NPS2143 and U73122, respectively, but not affected by Cav channels antagonists.
Elevating [Ca(2+)]o induced SOCE by triggering the activation of CaSR and PLC. This process was involved in osteoblastic proliferation induced by high level of extracellular Ca(2+) concentration.
在骨重塑过程中,骨微环境中细胞外Ca(2+)([Ca(2+)]o)的局部浓度会累积。在本研究中,我们调查了升高[Ca(2+)]o是否会在原代大鼠颅骨成骨细胞中诱导储存-操作性钙内流(SOCE),并进一步研究升高[Ca(2+)]o对成骨细胞增殖的作用。
使用钙敏探针fura-2/AM通过荧光成像检测原代培养大鼠成骨细胞的胞质Ca(2+)浓度([Ca(2+)]c)。通过细胞计数、MTS分析和ATP分析评估成骨细胞增殖。应用钙敏感受体(CaSR)的激动剂和拮抗剂以及磷脂酶C(PLC)、SOCE和电压门控钙(Cav)通道的抑制剂来详细研究其机制。
我们的数据表明,升高[Ca(2+)]o以剂量依赖的方式引起[Ca(2+)]c的持续增加。这种[Ca(2+)]c的增加分别被TMB-8(Ca(2+)释放抑制剂)、2-APB和BTP-2(均为SOCE阻滞剂)阻断,而不受Cav通道阻滞剂硝苯地平和维拉帕米的影响。此外,NPS2143(一种CaSR拮抗剂)或U73122(一种PLC抑制剂)强烈降低了[Ca(2+)]o诱导的[Ca(2+)]c增加。当用CaSR激动剂精胺刺激细胞时,观察到类似的反应。这些数据表明,升高[Ca(2+)]o导致SOCE,这取决于成骨细胞中CaSR和PLC的激活。此外,高[Ca(2+)]o显著促进成骨细胞增殖,分别被BAPTA-AM(一种细胞内钙螯合剂)、2-APB、BTP-2、TMB-8、NPS2143和U73122显著逆转,但不受Cav通道拮抗剂的影响。
升高[Ca(2+)]o通过触发CaSR和PLC的激活诱导SOCE。这一过程参与了高细胞外Ca(2+)浓度诱导的成骨细胞增殖。